-transparent.png){kind=logo}
Oxidation of low density lipoprotein (LDL) leads to more rapid uptake by arterial wall macrophages and foam cell formation. Inhibiting LDL oxidation may impede these processes and offers a new mechanism to retard atherogenesis. The 21-aminosteroids, derived from methylprednisolone, are potent inhibitors of free radical production by stimulated monocytes and also are scavengers of lipid peroxyl radicals. The 21-aminosteroid, U74500A, was added to a mixture of low density lipoprotein cholesterol and human monocytes to which lipopolysaccharide was add to stimulate the monocytes. At a final concentration of 10 microM, U74500A reduced the production of lipid peroxidation from 6.10 +/- 1.11 to 0.84 +/- 0.16 nmol (mean +/- SEM) MDA equivalent/1 x 10(6) monocytes, as measured by a thiobarbituric acid reacting substance (TBARS) assay. Similarly 10 microns U74500A reduced Cu2+ induced LDL oxidation from 12.28 +/- 0.10 (in vehicle) to 0.49 +/- 0.12. These observations suggest that the 21-aminosteroids should be evaluated in animal models as a potential therapy to retard atherogenesis, especially considering their apparent lack of mineralocorticoid and glucocorticoid side-effects.
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 1987,
Arteriosclerosis (Dallas, Tex.),
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 2000,
Research communications in molecular pathology and pharmacology,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 1998,
Life sciences,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 1999,
Life sciences,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 1988,
Basic life sciences,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 2010,
Indian journal of clinical biochemistry : IJCB,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
April 2005,
Bioscience, biotechnology, and biochemistry,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
December 1992,
Atherosclerosis,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
January 1998,
Life sciences,
M Fisher, and
P H Levine, and
E M Doyle, and
M M Arpano, and
J J Hoogasian
August 1995,
Endocrine journal,
